Is SpaceX Stock a Buy Before Its First Earnings Report as a Public Company?

SpaceX is preparing for its first public-company earnings report (expected in early August) after major catalysts including acquiring Cursor for $60B in stock and holding just over $100B in cash. Despite long-term upside tied to a $28.5T AI-focused TAM, the article flags near-term risk given a valuation around 118x revenue and revenue growth at Starlink slowing from 96.4% (2024) to 49.8% (last year). The takeaway is caution: investors may reassess if the first earnings and management tone don’t justify the premium.

Analysis

SPCX is trading less like a company with near-term fundamental visibility and more like a duration asset priced on a very distant terminal story. At a triple-digit sales multiple, the first earnings print matters mainly as a credibility test: if management cannot convert the AI/space narrative into measurable backlog, guidance cadence, or margin inflection, the stock can de-rate 20-30% quickly even on decent reported growth.

The second-order winner is not the company’s existing revenue base but any vendor tied to actual deployment of capital: launch hardware, networking, and compute suppliers would only benefit if the cash is translated into contracted spend rather than headline announcements. NVDA is the obvious sentiment proxy, but the linkage is indirect and likely premature; until there is signed demand, the market should treat “space data centers” as optionality, not order flow.

The contrarian risk is that investors are extrapolating TAM, not monetization. A public listing usually forces a narrower narrative and tighter expectations, so if the first call is heavy on vision and light on financial milestones, momentum investors may rotate out of the most expensive growth duration in the tape. What would falsify the bearish setup is a clear step-up in recurring revenue growth, concrete enterprise/government contracts, or evidence that new capital is immediately monetizable rather than being consumed by moonshot R&D.

Key Decisions for Investors

• Avoid initiating a long in SPCX into the first earnings print; wait 1-2 weeks post-call for a better read on guide quality and whether the market rewards vision or cash-flow visibility.
• If options are liquid, buy a 1-2 month SPCX put spread sized small against event risk; the thesis is multiple compression after the first credibility test, with defined downside if the print is strong.
• Pair trade: long NVDA / short SPCX on a 4-8 week horizon as a relative-value expression of "realized AI cash flow" versus "AI optionality." Cover the short if SPCX shows booked demand rather than aspirational commentary.
• Set an alert for any upward revision to recurring revenue or explicit customer contract disclosures; that would be the first signal the valuation can stay elevated for 6-12 months.
• If SPCX gaps down 15%+ on earnings without a guide cut, consider that an overreaction and watch for stabilization before adding to the short; the trade only works if the market starts demanding proof, not promises.